Researcher profile · Semantic Scholar

M. Caldano

h-index: 15
Works: 30
Citations: 763

Most-cited papers

Predictive markers for response to interferon therapy in patients with multiple sclerosis
S. Malucchi, F. Gilli, M. Caldano, F. Marnetto +5 more
2008Neurology98 citations Open access
Semantic Scholar
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1
F. Gilli, F. Marnetto, M. Caldano, A. Sala +3 more
2006Multiple Sclerosis98 citations
Semantic Scholar
Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
A. Bertolotto, A. Sala, M. Caldano, M. Capobianco +3 more
2007JIM - Journal of Immunological Methods63 citations
Semantic Scholar
Cotugno and cerebrospinal fluid
A. Bertolotto, A. Sala, S. Malucchi, F. Marnetto +4 more
2004Journal of Neurology Neurosurgery & Psychiatry62 citations Open access
Semantic Scholar
Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.
F. Gilli, F. Marnetto, M. Caldano, A. Sala +4 more
2005Journal of Neuroimmunology59 citations
Semantic Scholar
Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis.
F. Gilli, N. Navone, S. Perga, F. Marnetto +5 more
2011Archives of Neurology48 citations Open access
Semantic Scholar
The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
Md. Jakir Hossain, E. Morandi, R. Tanasescu, N. Frakich +5 more
2018Frontiers in Immunology44 citations Open access
Semantic Scholar
Expression and regulation of IFN / receptor in IFN -treated patients with multiple sclerosis
F. Gilli, P. Valentino, M. Caldano, L. Granieri +5 more
200836 citations Open access
Semantic Scholar
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
N. Clemente, C. Comi, Davide Raineri, G. Cappellano +15 more
2017Frontiers in Immunology34 citations Open access
Semantic Scholar
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis
S. Perga, Alessandra Giuliano Albo, K. Lis, N. Minari +9 more
2015PLoS ONE33 citations Open access
Semantic Scholar
One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients
S. Malucchi, F. Gilli, M. Caldano, A. Sala +4 more
2011Journal of Neurology27 citations
Semantic Scholar
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells
M. Spadaro, M. Caldano, F. Marnetto, A. Lugaresi +1 more
2015Journal of Neuroinflammation22 citations Open access
Semantic Scholar
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
A. Bertolotto, L. Granieri, F. Marnetto, P. Valentino +7 more
2015Cytokine & growth factor reviews20 citations Open access
Semantic Scholar
Anti-interferon-β neutralising activity is not entirely mediated by antibodies
F. Gilli, F. Marnetto, M. Caldano, P. Valentino +8 more
200720 citations Open access
Semantic Scholar
Anti-interferon-beta neutralising activity is not entirely mediated by antibodies.
F. Gilli, F. Marnetto, M. Caldano, P. Valentino +8 more
2007Journal of Neuroimmunology19 citations
Semantic Scholar
Interferon-β bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice
L. F. van der Voort, A. Kok, A. Visser, C. Oudejans +5 more
2009Multiple Sclerosis15 citations
Semantic Scholar
Qualitative and quantitative analysis of antibody response against IFNβ in patients with multiple sclerosis
F. Gilli, F. Hoffmann, A. Sala, F. Marnetto +5 more
200615 citations Open access
Semantic Scholar
Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.
F. Marnetto, P. Valentino, M. Caldano, A. Bertolotto
2017JIM - Journal of Immunological Methods11 citations Open access
Semantic Scholar
Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents
M. Caldano, W. Raoul, T. Rispens, A. Bertolotto
2017Therapeutic Drug Monitoring10 citations Open access
Semantic Scholar
Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod
F. Montarolo, S. Perga, S. Martire, F. Brescia +4 more
2018European Journal of Neurology9 citations
Semantic Scholar
Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis.
F. Gilli, F. Hoffmann, A. Sala, F. Marnetto +5 more
2006Multiple Sclerosis8 citations
Semantic Scholar
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
S. Romano, M. Ferraldeschi, F. Bagnato, R. Mechelli +13 more
2019Frontiers in Neurology7 citations Open access
Semantic Scholar
Comparison of three PCR assays for the evaluation of interferon-β biological activity in patients with multiple sclerosis
F. Gilli, F. Marnetto, G. Stefanuto, V. Rinaldi +6 more
2012Molecular diagnosis (Print)5 citations
Semantic Scholar
P14.27 Exploring end-of-life care in the GlioCova national brain tumour patient cohort
R. Mauricaite, K. Le Calvez, J. Droney, M. Caldano +2 more
2021Neuro-Oncology0 citations Open access
Semantic Scholar
Peg-Interferon beta 1a induces a sustained and long lasting overexpression of interferon related genes. (P3.2-073)
A. Bertolotto, M. Caldano, M. Arigoni, Martina Olivero +5 more
2019Neurology0 citations
Semantic Scholar
Quantification of anti-KIR4.1 Antibodies in Multiple Sclerosis: Difficulties and Acceptance Criteria (P5.341)
A. Bertolotto, M. Caldano, P. Valentino, F. Marnetto
2016Neurology0 citations
Semantic Scholar
Additional file 1: Figure S1 of Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells
M. Spadaro, M. Caldano, F. Marnetto, A. Lugaresi +1 more
20150 citations
Semantic Scholar
Chapter 2 . 1 Reduced biological activity of recombinant IFN-β and treatment response IFN-β bioactivity measurement in MS : feasibility for routine clinical practice
L. F. van der Voort, A. Kok, A. Visser, C. Oudejans +9 more
20140 citations
Semantic Scholar
IRF 5 gene variants and pharmacologi al and clinical outcome of IFN-β therapy in MS
L. F. van der Voort, A. Kok, A. Visser, C. Oudejans +20 more
20140 citations
Semantic Scholar
Effect of Natalizumab treatment on circulating CD4+ CD62L+ T-cells in Multiple Sclerosis patients
A. Bertolotto, F. Marnetto, M. Caldano, A. Lugaresi +1 more
20140 citations
Semantic Scholar

A. Sala

×13

M. Capobianco×13

P. Valentino×8

L. Granieri×6

A. Di Sapio×5

R. Lindberg×4

L. F. van der Voort×4

J. Killestein×4